InSyBio Suite Version 3.1 is released facilitating interactive and efficient network and machine-learning driven multi-omics data analysis

An increasing number of pharma and academic labs are getting access to multi-omics and multi-modal datasets. However, their processing requires multiple tools, while network analytics and data visualization can become challenging considering the high dimensionality, complexity and the presence of mutual information among different omics technologies. Moreover, predictive analytics using multi-omics data suffers from the curse of dimensionality and its performance is highly affected by data missingness and class imbalance leading to reduced reproducibility and classification metrics. With previous versions of InSyBio Suite. we have simplified multi-omics analysis providing optimized pipelines for preprocessing omics data and network and machine learning methods for the identification of biomarkers and training and testing predicting models.

The newly introduced version (version 3.1) of InSyBio Suite:

  • Αllows for the first time the reconstruction and analysis of multi-omics networks (InSyBio BioNets),
  • Provides an interactive environment for network visualization allowing the user-friendly projection of differential expression results on networks and their customization to summarize additional information and characterisation of the nodes (InSyBio BioNets).
  • Introduces the use of Adaptive Boosting for solving the class imbalance problem in predictive analytics for biomarker discovery by expanding the dataset with technical data samples newar the classification hyperplane (InSyBio Biomarkers).

InSyBio is offering a one-month free license to use InSyBio Suite. Request your free trial now by completing a simple form at:

About InSyBio: InSyBio is an international pioneer biotechnology company revolutionizing the medical field, clinical trials and food/nutrition industries through targeted biomarker discovery, highly-accurate predictive analytics and the development of personalization tests for drugs, nutraceuticals and nutrition products.

Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies, with the means both analytically and computationally to meet their challenging research and innovation goals (such as robust biomarker discovery and accurate predictive models).  This is done through a   sophisticated, software-as-a-service, machine learning platform which comprehensively integrates multi-omics data reducing the number of samples and additional validation experiments needed. Since 2013, InSyBio has worked with hundreds of academics, large and small companies, hospitals and research centers allowing them to succeed in their biomarker discovery tasks with an increase of at least 10% in predictive accuracy and a decrease of at least 80% in overall time and cost.

Visit to see how InSyBio can help you reach your R&D goals in the era of Precision Medicine and Nutrition. For more News visit our InSyBio Blog.

Scroll to top